Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial

20246 citationsJournal Articlegold Open Access

Authors

Ming-Ci Cai · Shanghai Jiao Tong University

Shu Cheng · Shanghai Jiao Tong University

Hongmei Jing · Peking University Third Hospital

Yan Liu · Shanghai Jiao Tong University

Guohui Cui · Union Hospital

Ting Niu · West China Hospital of Sichuan University

Jianzhen Shen ·

Abstract

This study was supported by the National Key Research and Development Program (2022YFC2502600) and the General Program of the Shanghai Municipal Health Commission (202040400).

Topics & Keywords

Lymphoma Diagnosis and Treatment T-cell and Retrovirus Studies Viral-associated cancers and disorders

Publication Details

Published in: The Lancet Regional Health - Western Pacific

Volume 50, pp. 101160-101160

DOI: 10.1016/j.lanwpc.2024.101160

Field-Weighted Citation Impact: 2.57

Command Palette

Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial

Authors

Abstract

Topics & Keywords

Publication Details